tcip3041 Recombinant Influenza Hemagglutinin (H9 Hong Kong) Full-Length Glycoprotein (rHA GP)

Data sheet

Download PDF Datasheet

Technical Inquries

Submit Review

Product Description

Recombinant, Influenza Hemagglutinin Full-Length Glycoprotein (rHA GP) from virus strain A/Hong Kong/33982/2009 (H9N2). Recombinant HA is supplied as an affinity purified protein. rHA is produced in Sf9 insect cells using baculovirus for expression and is purified by FPLC

Information

ApplicationELISA, WB
Research AreaVirology

Specifications

FormFrozen Liquid
ConcentrationSupplied at a concentration of 0.33 mg/mL (by BCA) in Tris buffered saline plus 0.01% non-ionic detergent. ; The theoretical molecular weight of the protein is ~63 kDa, without glycosylation. Because of the highly glycosylated nature of this protein, mig
Recommended DilutionWestern Blot: Quality control testing demonstrates detection of GP null under reduced conditions when using anti-H9 influenza antiserum.

Hemagglutination with Turkey Red Blood Cells: HA Titer 1:32
768
Purity / GradeColumn chromatography (FPLC); Purity: Residual baculovirus GP64 co-purifies with the affinity purified rHA GP and was determined to be less the 10% of the total protein.

Misc Information

Storage Instruction2-3 weeks at -20°C, long term It is recommended to dispense single-use aliquots and store aliquots at -80°C to avoid multiple freeze/thaw cycles
RelevanceRecombinant hemagglutinin glycoprotein provides a control protein for immunoassays and a tool to enhance Orthomyxovirus research.
Get valuable resources and offers directly to your email.